United States · How much has Genprex raised?
Genprex has raised $12M across 4 rounds since 2013.
20142015201620172018
$500KVenture$1.5MVenture$160KVenture$10MRound
United States · Funded startup
Who invested in Genprex
4 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Genprex and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$12Mraised across 4 rounds since 2013, from 4 sources
$500KVenture$1.5MVenture$160KVenture$10MRound
- Latest round
- Round, $10MMay 2018
- Step-upi
- 62.5×
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $500K Dec 2013
- Biggest round
- $10M Round · May 2018
- Usual gap between rounds
- 3.2 years the median of 2
The rounds
- May 2018Round$10M
No investor was named in the report.
Reported by FinSMEsSEC filing: $10M sold, first sale May 2018
- Mar 2015Venture$160K
No investor was named in the report.
From a historical funding recordSEC filing: $160K sold, first sale Feb 2015
- Dec 2013Venture$1.5M
No investor was named in the report.
From a historical funding recordSEC filing: $1.4M sold, first sale Dec 2013
- Dec 2013Venture$500K
No investor was named in the report.
From a historical funding recordSEC filing: $500K sold, first sale Dec 2013
Funding filed with regulators
Genprex filed 5 raises, $12M in all. Filings say how much was sold and to how many investors; they never name the investors.
- May 2018$10MSEC Form D
- Sept 2016$950KSEC Form D
- Feb 2015$160KSEC Form D
- Dec 2013$100KSEC Form D
- Dec 2013$500KSEC Form D
Founders and team
From Genprex's own website and the SEC filings it signed: 10 on the team.
- Kate CombsVice President of Clinical Operations
- Celina LaneyChief of Staff
- Christian ClementsClinical Trial Finance Payment Specialist
- Jackie CentenoClinical Program Director
- Kalyn DabbsDirector of Communications
- Olivia StancilIn-House Clinical Research Associate
- Pier-Anne LachanceSenior Director of Quality Control & Product Development
- John Rodney VarnerExecutive Officer, Directori
- Julien Rodney PhamExecutive Officeri
- Ryan Rodney ConferExecutive Officeri
On the board, as filediDavid Rodney FriedmanRobert Rodney Pearson
Quick answers about Genprex
When did Genprex last raise?
Genprex's most recent round was an Undisclosed round of $10M in May 2018.
What was Genprex's biggest round?
Its most recent round, $10M in May 2018, is also its largest on record.
What stage is Genprex at?
Genprex's latest named round is an Undisclosed round, in May 2018.
Where is Genprex based?
Genprex is based in the United States.
Companies like Genprex
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.